Source: Blood advances. Unidades: FM, FMRP
Subjects: LEUCEMIA MIELOIDE, CITOGENÉTICA, BRASILEIROS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Fernanda Borges da et al. The application of an integrated clinical, cytogenetic, and molecular risk stratification for acute myeloid leukemia patients using a central laboratory in a Brazilian multicentric study. Blood advances, v. 1, p. 86-89, 2017Tradução . . Disponível em: https://doi.org/10.1182/bloodadvances.2017GS102419. Acesso em: 04 nov. 2024.APA
Silva, F. B. da, Figueiredo-Pontes, L. L. de, Madeira, M. I. A., Koury, L. C. de A., Lima, A. S. G. de, Scheucher, P. S., et al. (2017). The application of an integrated clinical, cytogenetic, and molecular risk stratification for acute myeloid leukemia patients using a central laboratory in a Brazilian multicentric study. Blood advances, 1, 86-89. doi:10.1182/bloodadvances.2017GS102419NLM
Silva FB da, Figueiredo-Pontes LL de, Madeira MIA, Koury LC de A, Lima ASG de, Scheucher PS, Coelho-Silva JL, Velloso EDRP, Rego EM, Traina F. The application of an integrated clinical, cytogenetic, and molecular risk stratification for acute myeloid leukemia patients using a central laboratory in a Brazilian multicentric study [Internet]. Blood advances. 2017 ; 1 86-89.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1182/bloodadvances.2017GS102419Vancouver
Silva FB da, Figueiredo-Pontes LL de, Madeira MIA, Koury LC de A, Lima ASG de, Scheucher PS, Coelho-Silva JL, Velloso EDRP, Rego EM, Traina F. The application of an integrated clinical, cytogenetic, and molecular risk stratification for acute myeloid leukemia patients using a central laboratory in a Brazilian multicentric study [Internet]. Blood advances. 2017 ; 1 86-89.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1182/bloodadvances.2017GS102419
